Ignite Creation Date:
2025-12-24 @ 2:25 PM
Ignite Modification Date:
2026-01-02 @ 7:30 AM
Study NCT ID:
NCT04846959
Status:
RECRUITING
Last Update Posted:
2025-07-17
First Post:
2021-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-30
Start Date Type:
ACTUAL
Primary Completion Date:
2032-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-06
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-14
First Submit QC Date:
None
Study First Post Date:
2021-04-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-15
Last Update Post Date:
2025-07-17
Last Update Post Date Type:
ACTUAL